Arachnoid cyst and chronic subdural haematoma in a child with osteogenesis imperfecta type III resulting from the substitution of glycine 1006 by alanine in the pro α2(I) chain of type I procollagen

Journal of Medical Genetics

Volumn 33, Issue 3, 1996, Pages 193-196

  Cole, W G ^a   Lam, T P ^a  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

Author keywords

Arachnoid cyst; Os teogenesis irnperfecta type III; Subdural haematoma

Indexed keywords

ALANINE; GLYCINE; PROCOLLAGEN;

AMINO ACID SUBSTITUTION; ARTICLE; BRAIN ARACHNOID CYST; BRAIN VENTRICLE DILATATION; CALVARIA; CASE REPORT; CEREBROSPINAL FLUID PRESSURE; CLINICAL FEATURE; CORTICAL BONE; FRACTURE; HAVERSIAN CANAL; HUMAN; HUMAN CELL; LONG BONE; MALE; OSTEOGENESIS IMPERFECTA; OSTEOPENIA; PELVIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCLERA; SHOULDER GIRDLE; SKULL INJURY; SUBDURAL HEMATOMA; TIBIA SHAFT; VERTEBRA;

ADULT; ALANINE; ARACHNOID CYSTS; FEMALE; GLYCINE; HEMATOMA, SUBDURAL; HETEROZYGOTE DETECTION; HUMANS; INFANT; MALE; OSTEOGENESIS IMPERFECTA; POINT MUTATION; PROCOLLAGEN; SKULL; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0030048530     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Sillence DO, Senn A, Danks DM. Genetic heterogeneity in osteogenesis imperfecta. J Med Genet 1979;16:101-16.
2. Sillence DO, Barlow KK, Cole WG, Dietrich S, Garber AP, Rimoin DL. Osteogenesis imperfecta type III delineation of the phenotype with reference to genetic heterogeneity. Am J Hum Genet 1986;23:821-32.
3. Byers PH, Wallis GA, Willing MC. Osteogenesis imperfecta: translation of mutation to phenotype. J Med Genet 1991;28:433-42.
4. Lu J, Costa T, Cole WG. A novel G1006A substitution in the α2 (I) chain of type I collagen produces osteogenesis imperfecta type III. Hum Mutat 1995;5:175-8.
5. Bailey JA. Forms of dwarfism recognizable at birth. Clin Orthop 1971;76:150-9.
6. Tokoro K, Nakajima F, Yamataki A. Infantile chronic subdural hematoma with local protrusion of the skull in a case of osteogenesis imperfecta. Neurosurgery 1988;22:595-8.
7. Martinez-Lage JF, Poza M, Sola J, Puche A. Congenital arachnoid cyst of the lateral ventricles in children. Childs Nerv Syst 1992;8:203-6.
8. Pomeranz S, Constantini S, Lubetzki-Korn I, Amir N. Familial intracranial arachnoid cysts. Childs Nerv Syst 1991;7:100-2.
9. Eustace S, Toland J, Stack J. CT and MRI of arachnoid cyst with complicating intracystic and subdural haemorrhage. J Comput Assist Tomogr 1992;16:995-7.
10. Sztrolovics R, Glorieux FH, Travers R, van der Rest M, Roughly PJ. Osteogenesis imperfecta: comparison of molecular defects with bone histological changes. Bone 1994;15:321-8.
11. Cole WG, Chow CW, Rogers JG, Bateman JF. The clinical features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by arginine in the pro α(1(I) chain of type I procollagen. J Med Genet 1990;27:228-35.
12. Cole WG, Patterson E, Bonadio J, Campbell PE, Fortune DW. The clinicopathological features of three babies with osteogenesis imperfecta resulting from the substitution of glycine by valine in the proα1(I) chain of type I procollagen. J Med Genet 1992;29:112-8.
13. Cohen-Solal L, Zylberberg L, Sangalli A, Gomez Lira M, Mottes M. Substitution of an aspartic acid for glycine 700 in the α2(I) chain of type I collagen in a recurrent lethal type II osteogenesis imperfecta dramatically affects the mineralization of bone. J Biol Chem 1994:269:14751-8.
14. Lamande SR, Dahl HH, Cole WG, Bateman JF. Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. J Biol Chan 1989;264:15809-12.
15. Valli M, Sangalli A, Rossi A, et al. Osteogenesis imperfecta and type-I collagen mutations. A lethal variant caused by a Gly910→Ala substitution in the alpha 1(1) chain. Eur J Biochem 1993;211:415-9.